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Friend leukemia virus, which produces a rapidly developing erythroleukemia 
in adult mice of susceptible strains, is a complex of defective Friend spleen focus- 
forming virus (SFFV) ~ and its helper lymphatic leukemia virus (1). Resistance 
to leukemogenesis by Friend virus complex (FV) is controlled by a  number of 
genes  (2).  The  Friend  virus-2  (Fv-2)  locus  controls  host  resistance  to  SFFV. 
Adult homozygous resistant mice  (Fv-2 rr) such as C57BL/6  (B6) and  C58,  are 
completely resistant  to  the  erythroleukemic effects of FV  (2)  and  relatively 
resistant to immunosuppression by FV  (3). 
In the first paper of this series (4), we reported that genetically resistant mice possess 
erythropoietic target cells susceptible to transformation by FV,obut seem to be protected 
from developing leukemia by a special class of  effector  cells which are responsible for bone 
marrow allograft rejection. The effector cell system responsible for marrow  allograft 
rejection differs in several characteristics from thymus (T)- and bursa equivalent (B)- 
dependent cells of  the mouse (5). Two cell types, which may or may not be related, seem to 
be involved in the rejection of bone marrow allografts. These are marrow-dependent (M) 
cells and macrophages. The M cells appear to require a bone marrow microenvironment 
for a critical stage in maturation since their function is suppressd by the long-lived bone- 
seeking isotope ""Sr (6). T-, B-, and macrophage-cell functions, e.g. humoral immunity, 
graft-vs.-host reactivity, response to T- and B-cell mitogens,  and antibody-dependent 
cellular cytotoxicity, appear intact in mice treated with s:'Sr (6,  7).  The macrophages 
involved in marrow allograft rejection are suppressible by injection of silica particles (8). 
Treatment of mice with ""Sr not only abrogates their ability to reject allogeneic bone 
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marrow cells, but also the genetic resistance of B6 mice to Friend virus-induced erythro- 
leukemia, suggesting a  surveillance role for M cells (4). 
The mechanism of M-cell-mediated surveillance is not clear. M cells recognize Hemo- 
poietic  histocompatibility (Hh)  antigens which  are  expressed  normally on  primitive 
hemopoietic cells. Expression of certain Hh antigens is increased several fold on erythro- 
poietic progenitor cells transformed by FV (9). Therefore, M cells of resistant mice may 
act  by  "rejecting"  transformed  cells.  Alternatively or  additionally, M  cells  may  act 
indirectly by antagonizing  the suppressive effects of FV on T and B cells, thus permitting 
the latter to reject leukemic cells. Suppression of T- and B-cell function in vivo seems to 
be  a  consistent effect  of FV  in  strains  of mice  susceptible to  leukemia,  but  not  in 
genetically resistant strains of mice (3,  10). 
We have been able to investigate the regulatory role of M  cells on suppression 
ofT and B cells by FV using an in vitro technique. We have observed that FV, in 
vitro, can suppress the proliferative responses to mitogens oflymphocytes taken 
from mice susceptible to the immunosuppressive and erythroleukemic effects of 
FV in vivo, and vice versa. In this paper we describe experiments which indicate 
that functional M cells are responsible for the resistance oflymphocytes to FV in 
vitro. In the accompanying paper (11) experiments are described which indicate 
that a  subpopulation of T  cells mediate the FV-induced suppression of lympho- 
cyte mitogenesis. In both these papers the terms "in vitro susceptibility/resist- 
ance" are intended to imply the suppression or lack of suppression of lymphocyte 
mitogenesis by FV. 
Materials  and  Methods 
Mice.  Adult male mice of the strains B6,  DBA/2J,  B10.D2/nSn  (B10.D2), 129/J, and C58/J 
were  purchased from The Jackson Laboratory, Bar Harbor, Maine. BALB/c and C3H/He mice 
were bred in our own animal facility. Mice were 6- to 8-wk old in most instances. 
Virus.  NB-tropic  FV,  as contained in the Mirand strain (12) was used.  The virus is main- 
tained by serial in vivo passages in BALB/c mice and virus stocks are prepared as 20% wt/vol cell- 
free extracts of leukemic spleens. The virus is titrated by the spleen focus assay (13). 
Culture of Lymphoid  Cells.  Cell  suspensions were  made from  spleens, lymph nodes,  bone 
marrow, and thymuses of normal mice in chilled RPMI 1640 medium with 10% fetal calf serum. 
Lymph node and thymus cells were  routinely washed once in cold medium. Spleen cells were 
washed or not, dependent upon the experimental protocol as described in the Results. Cells were 
cultured in Falcon Microtest  II plates  (Falcon Plastics, Div.  of BioQuest,  Oxnard, Calif.)  (10  ~ 
nucleated cells per well).  Each cell suspension was cultured in 0.2 ml vol in triplicate with (a) 
mitogen only, (b) mitogen plus FV, (c) FV only, or (d) neither FV nor mitogen. In each experiment 
at least three doses of FV ranging from 100-500 spleen focus-forming units (FFU)/well were used. 
The virus, after appropriate dilution in the culture medium, was added in 25-iLl vol at the onset of 
cuture. PHlthymidine (0.5 ttCi; New England Nuclear, Boston, Mass.) was added to each well 48 h 
after plating and the cultures were harvested 18 h later by a MASH II cell harvester (Microbiologi- 
cal  Associates,  Bethesda,  Md.)  Incorporation of  PH]thymidine into  DNA,  as  detected  by  a 
standard liquid scintillation  counting  procedure,  was the measure of cell proliferation. Results are 
expressed  as A blastogenesis which represents mean counts per minute in cultures stimulated 
with mitogen minus mean counts per minute in cultures without the mitogen. To calculate A 
blastogenesis in the presence of FV,  the counts per minute in wells with FV alone were sub- 
stractod from counts per minute in wells with FV and the mitogen. FV without mitogen did not 
have any significant effect  on  incorporation values of PHlthymidine. Therefore,  FV-induced 
changes in A blastogenesis could  not be attributed to  changes in "background" counts.  The 
percentage (%) suppression of A blastogenesis in cultures with FV was calculated as follows: % 
suppression = A blastogenesis (control-FV)/(control)  x  100. 
Mitogens.  Concanavalin A  (Con A)  (Calbiochem,  San Diego,  Calif.)  was used as a  T-cell VINAY  KUMAR  AND  MICHAEL  BENNETT  715 
mitogen and after preliminary experiments, 2, 1, and 0.25 tLg/well were selected as optimal doses 
for thymus, spleen, and lymph node cells, respectively. Salmonella typhi lipopolysaccharide (LPS) 
(Difco Laboratories, Detroit, Mich.) was used as one of the B-cell mitogens in a dose of 2.5 t~g/well 
both for spleen and lymph node cells. Bone marrow and splenic B cells were also stimulated with 
dextran sulfate (DS) (Pharmacia Fine Chemicals, Inc., Piseataway, N. J.) at a dose of 300 t~g/well. 
Transplantation of Methylcholanthrene-Induced  (MC)  Sarcoma  in B6 Mice.  Details  of this 
have  been  published  (15).  Briefly,  B6  mice  inoculated  subcutaneously  in  the  thigh with  10  '~ 
syngeneic MC sarcoma cells. Mice were used when the tumor reached a diameter of 2.0-2.5 cm 15 
days after inoculation of tumor cells. Under these conditions, B6 mice lose the ability to reject bone 
marrow allografts (15). 
Neutralization of FV Preparation.  Stock FV as contained in the leukemic spleen cell extract 
was incubated at 37°C either with an equal volume of normal Swiss mouse serum (NMS) or with 
an anti-FV serum prepared in Swiss mice.  The details of preparing this antiserum have been 
published (14). At 40 and 80 min after the onset of incubation, 0.1-ml aliquots of FV incubated with 
NMS or anti-FV serum were diluted to achieve a concentration of 200 FFU/25 t~l and then tested in 
vitro for ability to suppress the response of splenic T cells to Con A. Two other control groups were 
included to determine if NMS or anti-FV serum had any effect on the Con  A  response at the 
dilutions equal to those used in the incubation mixtures in culture wells. 
UV Light and Heat Treatment of  FV.  A 1.5 dilution of stock FV was exposed to UV irradiation 
(6  x  10  :* ergs) and then tested for its suppressive activity after dilution to an amount that would 
have been 200  FFU/25  ill  before  UV  irradiation.  Similarly,  a  1:5  dilution of stock  virus was 
incubated at 56°C for 45 min and then tested for its ability to suppress the Con A response. 
Administration of s"Sr.  100 t~Ci of ~"Sr (Oak Ridge National Laboratory, Oak Ridge, Tenn.) 
were infused intravenously on two separate occasions 4 wk apart. Mice were used for experiments 
3-5 wk after the last injection. This protocol successfully abrogates genetic resistance to incompat- 
ible marrow allografts (6) and to FV-induced leukemia in B6 mice (4). 
Administration  of Silica.  Silica  particles  (5  tLm  average  size,  gift  from  Dr. K.  Robock, 
Ste~rlkohlenberg Vauverein, 43 Essen-Krey,  Germany) were suspended in medium and injected 
intravenously  (5  mg/animal)  24  h  before  sacrifice  of mice.  This treatment in  mice  overcomes 
hybrid resistance and allogeneic resistance to incompatible hemopoietic cell grafts (8). 
Results 
Suppression  of Lymphoid  Cell Mitogenesis  by FV In  Vitro.  It  has  been 
reported that spleen cells from mice infected with Friend or Rauscher leukemia 
viruses respond poorly to phytohemagglutinin  (PHA), a T-cell mitogen (16,  17). 
The leukemic spleens, used 20 days after infection as a  source of cells in such 
experiments are markedly hypercellular due to proliferation of neoplastic eryth- 
roid cells  and  contain  large  amounts  of virus released from the  transformed 
cells. Thus, a reduced PHA response might have been due to marked dilution of 
T cells by the erythroid cells and/or a  direct suppressive effect of extracellular 
virus on the PHA-responsive T cells. To find out whether FV directly suppressed 
T- and B-cell mitogenesis, we cultured normal spleen, thymus, lymph node, and 
bone marrow  cells from  several  strains  of susceptible mice  with  appropriate 
mitogens  and  added  FV to  the  cultures  at  the  onset.  Results  collected from 
several experiments are shown in Table I. 
Addition of FV suppressed the mitogenic effects of Con A on splenic, thymic, 
and lymph node T cells in a dose-related fashion. Responses of lymph node and 
splenic B cells to DS or LPS and of primitive B cells in the bone marrow which 
respond only to DS, were also suppressed by FV. Although the virus effect was 
always dose related, the absolute degree of suppression at a  given dose of virus 
varied from one experiment to another by about 10-20%. 
Relation  of Suppressive  Activity of FV stocks  to Presence of Infective  Viri- b
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TABLE  II 
Requirement of Infective FV* to Suppress Con A-Induced  Mitogenesis of C3H Spleen 
Cells 
Prior treatment of FV  Blastogenesis 
Suppres- 
Exp.  FV (200 FFU/  sion 
Mode of treatment  Duration  No FV  well) 
min  mean cpm  ± SE  % 
None  69,731  ± 826  32,141  ±  309  54 
UV light $  40  63,168 -+ 1,016  10 
2  None  53,740 ± 282  23,076  ±  1,183  58 
Heat§  45  44,475 ±  558  18 
None  64,556 ±  1,142  33,219  ±  754  49 
Anti-FV antiseruml}  40  49,916 _+ 1,355  23 
Anti-FV antiserum  80  61,858 ±  2,382  5¶ 
Normal mouse serum  80  34,624 ±  1,459  47 
* FV extracted as a 20% cell-free suspension from spleens of leukemic BALB/c mice. 
A 1:5 dilution of FV was exposed to UV light (6 ×  10  :~ ergs/mm~). 
§ A 1:5 dilution of FV was heated at 56°C in a water bath and diluted to 200 FFU/25/xl in RPMI 
1640. 
II 0.2 ml FV preparation was incubated with equal volume of an anti-FV serum at 37°C. 40 and 80 
rain after incubation aliquots of 0.1 ml were removed and diluted to the desired concentration 
(200 FFU/25 ~l) with ice-cold RPM11640; the virus was then tested for ability to suppress the Con 
A-induced mitogenesis of C3H spleen cells. Controls consisted of FV not treated with antiserum 
or treated with normal mouse serum. 
¶ Not significantly different from control (No. FV) value (P >  0.05). Suppression induced by FV 
treated with heat, UV light, and anti-FV serum at 40 and 80 min was significantly (P < 0.05 as 
determined by Student's t test) less than untreated virus preparations. 
ons.  Leukemic spleen extracts, which were the sources of our FV preparations, 
might have contained nonviral soluble immunosuppressive  factors. Therefore, it 
was  important  to  determine  if the  effects of FV on  the  mitogen  response  was 
virus  associated.  If the  suppressive  effect  of leukemic  spleen  extracts  was  a 
function of live and infective virus, it would be expected to be sensitive to heat 
and UV irradiation. 
UV irradiation and heating  at 56°C for 45 min largely abolished the suppres- 
sion of Con A  response of C3H  spleen cells by FV  (Table II, exps.  1 and 2).  To 
confirm that it was FV and not other nonspecific immunosuppressive  factors or 
contaminating  viruses  which  are  responsible  for  the  in  vitro  suppression  of 
mitogenesis, we tested if prior incubation of our fully suppressive FV stock with 
an anti-FV  serum  would abolish the effect on Con A-responsive T  cells. 40 min 
after incubation with anti-FV  serum, the suppressive activity of FV was signifi- 
cantly reduced from 49 to 23%, and 80 min after incubation with the antiserum, 
the suppressive activity of FV was almost completely abrogated  (Table II, exp. 
3).  Incubation  with  NMS  for  80  rain  did  not  affect  the  immunosuppressive 
function of FV.  Since the anti-FV  serum  used neutralizes spleen focus-forming 
activity of FV, the results suggest that infectious virus is necessary for lympho- 
cyte suppression in vitro. 718  FRIEND  VIRUS SUPPRESSION OF  LYMPHOCYTES 
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Fro.  1.  The effect of adding washed or unwashed leukemic spleen cells on the proliferative 
response of normal splenic T cells. Spleen cells were harvested from normal BALB/c mice or 
those infected 4 days earlier with 10 :* FFU of FV complex. Half of the cells, from infected as 
well as control BALB/c mice, were washed three times in cold medium; the other half were 
used unwashed.  Both washed and unwashed ceils from normal and infected animals were 
cultured with Con A, either without mixing (100% normal and 100% leukemic) or in a series 
of mixtures containing nine different ratios of normal and transformed cells. The term 
"100% leukemic" indicates that all the cells were derived from mice infected with FV, and 
does not imply that every cell is malignant. Normal (100%) spleen cells were also cultured 
with Con A and a 100 t~l sample from the first washing of leukemic cells (which contained 
100 FFU of FV by spleen focus assay).  Result: Mitogenic response of T cells in unwashed 
cells from leukemic animals was suppressed; washing the cells brought it to control value. 
Neither washed  nor unwashed  leukemic cells showed any suppressive  interaction with 
normal cells, Washing from leukemic cells suppressed response of normal cells. 
Role of Leukemia  Virus vs. Leukemic  Cells in Suppressing the Con A  Re- 
sponse of Spleen Cells.  It has been suggested that the inability of splenic T 
cells from leukemic DBA/2 mice to respond to Con A may be due to a  "suppres- 
sor" action of Friend leukemic cells (17). Since we found FV itself  to be capable of 
suppressing Con A-induced mitogenesis, we decided to investigate whether the 
suppressive  function  ascribed  to  Friend  leukemic  cells  may  be  due  to  the 
extracellular virus present in the leukemic spleen cell preparation. Spleen cells 
from BALB/c mice infected 4 days earlier with 1,000 FFU of FV and spleen cells 
from control BALB/c mice were harvested. Half of the cells, both from control 
and leukemic mice, was washed three times in cold RPMI while the other half 
was  used  unwashed.  Samples  were  kept  from  each  wash  to  test  for  virus 
activity. Both  washed  and unwashed  normal and leukemic spleen cells were 
cultured either alone or in a series of mixtures containing nine different ratios of 
normal  and  leukemic  spleen  cells  (Fig.  1).  The  cells were  cultured  with  or 
without Con A, and no exogenous source of FV was added to the cell cultures. 
We reasoned that if addition of both washed and unwashed leukemic cells to 
normal  cells lowered the  Con  A  response,  the  suppressor function  could  be 
ascribed to leukemic cells. On the other hand,  if after washing, the leukemic 
cells lost their suppressive effects on normal spleen cell response to Con A, the VINAY  KUMAR  AND  MICHAEL  BENNETT 
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FIG. 2.  Effect  of adding washed leukemic  spleen cells from 12-day infected  BALB/c  mice 
on the Con A-responsive cells of normal spleens. Experimental design same as in Fig. 1. 
Result: Con A response of washed 100% leukemic  spleen cells markedly lower than control. 
Washed leukemic  spleen cells did not interact with normal splenic T cells to suppress their 
response to Con A. 
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suppressive effect in such case would be due to a  noncellular factor, probably 
FV. 
Unwashed leukemic spleen cells responded poorly to Con A (Fig. 1). Addition 
of increasing  numbers  of unwashed leukemic  cells  lowered the  response  of 
unwashed normal  spleen  cells to  Con  A,  proportionate to the percentage  of 
leukemic cells in the mixture. However, washed leukemic cells responded as 
well as washed normal cells to  Con A.  Thus,  4 days after FV infection, the 
decreased  response  of unwashed leukemic cells  to  Con  A  was  not  due  to  a 
dilution or decrease in frequency of the Con A-responsive cells. The procedure of 
washing normal spleen cells enhanced the response to mitogens (Fig. 1). This is 
a  consistent finding, but  the  supernatant fluids are  not  suppressive  to  the 
washed normal  spleen  cells.  We  also  tested the  supernatant fluid from the 
washing of leukemic cells, both for suppressive effect on the Con A response of 
normal spleen cells and for presence of FV complex. The first washing was both 
immunosuppressive (Fig.  1) and contained 1,000 FFU of FV/ml (total of 2,000 
FFU/spleen). 
We repeated similar experiments on days 8, 12, 13, and 21 after infection with 
FV. At these times, both virus titers and fraction of cells in leukemic spleen that 
were transformed are higher than at day 4.  Results of an experiment using 
washed 12 day leukemic spleen cells is shown in Fig. 2. Two important points 
can be made from these results.  Firstly, even after washing, the response of 
leukemic spleen cells is only 5% of control.  By 12 days after infection with a 
large dose of FV, the spleen was markedly enlarged (800 × 108 cells per spleen in 
leukemic vs. 96  ×  106 per spleen in control mice) with leukemic erythroid cells. 
Thus,  the frequency of Con A-responsive T  cells was greatly decreased.  Sec- 
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TABLE  III 
Strain Distribution of Susceptibility to FV-Induced Suppression of Mitogenic Response 
of T  and B  Cells 
A Blastogenesis 
Suppres-  Mouse  H-2  Lymphoid cell  Mitogen  +FV (200 FFU/  sion 
Exp.  strain*  type  source  No Fv 
well) 
mean cpm  ± SE  % 
1  DBA/2  d  Spleen  Con A  66,525  ± 2,409  17,879  ±  77  84 
B10.D2/n  d  Spleen  Con A  34,720  ± 2,334  30,398  ± 1,196  135 
2  129  b  Thymus  Con A  38,004  ±  457  8,432  ± 1,443  78 
B6  b  Thymus  Con A  22,370  ± 1,511  26,439  ± 1,177  -185 
3  C3H  k  Spleen  Con A  23,291 ± 2,348  9,809  ±  192  58 
C58  k  Spleen  Con A  65,107  ± 7,786  62,741 ±  248  45 
4  129  b  Spleen  LPS  66,152  ± 1,054  21,340  ±  487  68 
B6  b  Spleen  LPS  22,104  ±  98  17,295  _+  624  22 
5  DBA/2  d  Spleen  LPS  30,127  ±  813  7,621  ±  195  75 
B10.D2  d  Spleen  LPS  12,992  ±  123  9,312  _+  906  29 
6  129  b  Bone marrow  DS  11,295  ±  731  1,779  ±  319  85 
B6  b  Bone marrow  DS  23,119  ±  709  21,612  ± 1,171  75 
7  DBA/2  d  Bone marrow  DS  6,423  ±  367  2,729  ±  192  58 
B10.D2  d  Bone marrow  DS  12,776  ±  458  11,651  ±  250  95 
* DBA/2, 129, and C3H mice are susceptible to FV leukemia in vivo. DBA/2, 129, C3H, and C58 
mice possess the Fv-l" genotype. The rest, i.e., B10.D2  and B6 are Fv-1  ~. 
5 Not significantly different from control (No FV) value (P >  0.05). Suppression ofh blastogenesis 
was significantly greater (P <  0.05 as determined by Student's t test) in cells from susceptible 
donors in each experiment. 
cells was directly proportional to the number of responding cells present in the 
mixtures, i.e.,  the washed leukemic cells did not suppress the normal spleen 
cells. Similar results (data not known) were obtained with spleen cells harvested 
on days 13 and 21 after infection. 
Effect of  FV on the Mitogenic Response ofT and B Cells from Mice of  Different 
Strains.  In the experiments described so far, the effect of FV on mitogenesis of 
cells from mouse strains susceptible in vivo to leukemogenesis was tested. We 
next compared the effect of FV on B  and T  cells of several strains of mice to 
determine if the susceptibility to in vitro suppression of mitogenesis was under 
genetic control. In each pair,  both strains were Ho2  identical but were either 
susceptible (FV-2 ss) or resistant (Fv-2 rr) to Friend virus leukemogenesis. The 
Friend virus-1 (Fv-1) type within each pair was not always identical. Since the 
FV stock used was NB-tropic, the Fv-1  genotype was not taken into considera- 
tion in planning experiments. 
The results  (Table III) indicate that regardless of the H-2 type, the type of 
lymphoid cell (thymus, bone marrow, or spleen), or the mitogen used (Con A, 
LPS, or DS), there was a good correlation between the susceptibility to suppres- 
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FV. Thymocytes, splenic T and B cells, and bone marrow B cells from mice of 
resistant  strains  such  as  B6,  B10.D2,  and  C58  were  at  least  three  times  as 
resistant as similar cells from DBA/2, 129, and C3H mice. The data in Table III 
suggests that the Fv-2 gene controls this property of lymphocytes, but a genetic 
analysis has indicated that this is not so. 2 
Effect of 8~Sr on Genetic Resistance of B6 Mice to the Suppression of Con A 
Response by FV.  We next sought to determine whether the genetic resistance 
of mitogen-responsive  lymphocytes  to  the  suppressive  effect  of FV  was  an 
intrinsic property of T- and B-cell populations or was mediated by some other 
cell type.  Since suppression  of M  cells  in  adult  B6 mice  with sgSr abrogated 
resistance  to both the leukemogenic and  immunosuppressive effects of FV in 
vivo  (4),  it  seemed conceivable that  M  cells  sensitive  to  suppression  by s~Sr 
treatment  may also be responsible for the in vitro resistance  of T  cells to the 
suppressive effects of FV. Therefore,  adult B6 (>12-wk old) mice were treated 
with  100  /~Ci  of s~Sr twice  at  4-wk  intervals,  a  regimen  which  abrogates 
resistance of such mice to bone marrow cell allografts and to the leukemogenic 
effects of FV (4). The effect of FV on the mitogenic response of spleen cells from 
control and sgSr-treated B6 mice was compared. 
The mitogenic response to Con A of spleen cells from B6 mice treated with 8~Sr 
in the absence of FV was vigorous (Table IV, exps. 1 and 2). The A blastogenesis 
in cultures treated with Con A  without the virus was 30-35% lower in spleen 
cells from S'Sr-treated mice, apparently due to the dilution effect on T cells by 
the  increased  myelopoietic  activity  of  spleens  from  8~Sr-treated  mice  (18). 
Spleens from 8'Sr-treated animals were enlarged and contained 50% more cells 
than  controls  in  these  experiments  indicating  that  the  absolute  number  of 
responsive  T  cells  were  very  similar  in  spleens  of the  two  groups  of mice. 
However, unlike control adult B6 spleen cells, proliferation of spleen cells from 
B6  mice  treated  with  s~Sr was  as  susceptible  to  suppression  by FV  as  was 
mitogenesis of spleen cells from mice whose spleen cells are genetically suscepti- 
ble. Thus, abrogation of M-cell function by ssSr was associated with a loss of the 
genetic resistance of T-cell populations to the suppressive effects of FV in vitro. 
We next assessed the relevance of M cells to this phenomenon by an ontogenic 
approach.  M-cell function,  as  measured  by the  ability to reject bone marrow 
allografts, does not develop until 3 wk of age (5). Moreover, spleen cells of infant 
genetically resistant B10.D2 mice are less resistant to malignant transformation 
by  FV  as  compared  with  adult  B10.D2  mice  (19).  Since  M-cell  function  is 
deficient  in  untreated  infants  as  in  adults  treated  with  8'~Sr, we  tested  the 
susceptibility of thymus cells from 2-wk-old B6 mice to suppression by FV in 
vitro.  In  two  such  experiments  (Table  IV,  exps.  3  and  4),  the  blastogenic 
response of thymocytes from infant B6 mice was suppressed by FV. Thymocytes 
from 8- or 10-wk-old B6 mice were resistant. The mitogenic response of infant B6 
thymocytes in the absence of FV was vigorous, indicating that Con A-responsive 
cells had developed by this age. 
Effect of Silica and MC Sarcomas on Resistance of B6 Mice to FV-Induced 
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TABLE  IV 
Effect of Various Treatments or Age on the Susceptibility of T Cells from B6 Mice to FV 
A Blastogenesis 
Exp.  Treatment  Lymphoid cell  Suppres- 
source  +FV (200 FFU/  sion 
No FV 
well) 
cpm  +- SE  % 
1  -  Spleen  26,988  ±  6,723  31,300  ±  2,910  -15" 
ssSr$  Spleen  15,040  ±  2,221  7,486  ±  869  50 
2  -  Spleen  31,113  ±  2,566  28,121  +- 856  10" 
8'Sr  Spleen  22,219  -+  1,216  10,565  +-- 674  53 
3  Adults  Thymus  27,173  ±  2,716  22,084  ±  5,930  19" 
Infants§  Thymus  27,943  +-  1,219  10,868  +-  1,284  62 
4  Adults  Thymus  39,677  ±  1,138  37,520  +- 2,887  6* 
Infants§  Thymus  18,962  ±  1,518  7,714  _+  2,177  60 
5  -  Spleen  40,211  ±  588  37,015  _+  1,032  8 
Silicall  Spleen  42,806  +- 203  39,203  ±  152  9 
6  -  Spleen  67,891  ±  892  62,200  _+  940  9 
MC sarcoma¶  Spleen  27,470  ±  543  27,116  +_  536  2* 
* Not significantly different from controls (No FV) (P >  0.05). The suppression of h blastogenesis 
was significantly greater (P < 0.05) in cells from infant mice and adult mice treated with s'~Sr but 
not significantly greater in cells from adult mice treated with silica or MC sarcomas. 
$ B6 mice were injected with two doses of 100  ~Ci of x'Sr 4 wk apart. Mice were sacrificed 3 wk 
after the last dose of 8"Sr. 
§ 2 wk of age; all other mice were more than 8 wk of age. 
II Injection of 5 mg silica intravenously was given 24 h before sacrifice. 
¶ Mice inoculated with 10  '~ tumor cells from a transplantable MC sarcoma 15 days before sacrifice 
(15). 
Suppression.  Treatment of mice with silica (a macrophage poison) and growth 
of MC sarcomas in B6 mice are both associated with loss of ability to reject bone 
marrow allografts  (8,  15). Since both the above treatments mimic the effect of 
s~Sr on bone marrow allograft rejection, we tested whether the Con A response of 
spleen  cells  from  silica-treated  mice  and  MC  tumor-bearing  B6  mice  were 
suppressible  by FV.  However,  neither  of these  two treatments  rendered  B6 
lymphocytes susceptible to suppression by FV in vitro (Table IV, exps. 5 and 6). 
The low Con A responses of spleen cells from B6 mice bearing MC sarcomas have 
been  described previously and  shown  to  be due  to  splenomegaly with  T-cell 
dilution  (20). 
Discussion 
Friend leukemia virus,  which can cause a  rapidly developing erythroleuke- 
mia in genetically susceptible adult mice, has now been shown to be capable of 
suppressing the mitogenic response of T  and B  cells from lymphoid organs of 
adult susceptible mice. The observation that the FV-induced suppression was 
sensitive to heat and UV irradiation,  two well-known methods of inactivating 
viruses, indicates that suppression of mitogenic response was probably not an 
effect of soluble factors also present in FV containing spleen cell extracts. Since 
UV irradiation prevents replication of the virus without destroying its ability to VINAY  KUMAR  AND  MICHAEL  BENNETT  723 
adsorb and penetrate the cells, it follows that fully infectious virus is necessary 
for  suppression  in  vitro.  Abrogation  of suppression  by  type-specific  Friend 
antiserum makes it very unlikely that the suppression observed could be due to 
contaminating  viruses in our FV stocks. 
There are conflicting reports in the literature regarding the ability of murine 
leukemia viruses (MuLV) to suppress immune responses in vitro. In some other 
studies,  FV failed  to  suppress  humoral  antibody  synthesis  in  vitro  (21)  and 
certain FV preparations  failed to suppress the Con A  response of lymphocytes 
(17). However, clarified FV preparations directly suppressed humoral antibody 
synthesis against  sheep red cells in vitro  (22).  Other MuLV stocks have been 
shown to suppress PHA responses of lymphocytes in vitro (23). Our FV prepara- 
tions are consistently active in this assay. The inability of some investigators to 
detect suppression  of lymphocyte functions  by FV in  vitro  cannot  be clearly 
explained. It is interesting to note that other investigators could detect suppres- 
sion of immune responses and Con A  mitogenesis in vitro by using unwashed 
Friend erythroleukemic cells, leading them to conclude that leukemic cells were 
suppressors (17). Prior treatment of FV leukemic cells with X rays or mitomycin 
C  did not abrogate  their  suppressive effects (17) but treatment  with  anti-FV 
serum (without complement) did abolish the suppression (22). This supports our 
view that the virus per se and not leukemic cells are responsible for suppression. 
Experiments  reported here using mixtures of washed and unwashed leukemic 
cells indicate that virus present in the washings of the erythroleukemic cells and 
not  the  cells  themselves  are  suppressors.  We  deliberately  chose  to  test  the 
possible suppressor effects of spleen cells from early  (4  days) as  well as  late 
leukemic mice.  The reasons for testing spleen cells from mice infected 4 days 
earlier with FV were twofold. Within 4 days after infection, B-cell differentia- 
tion is already suppressed (24). In addition, early after infection, transformation 
of erythropoietic cells would have occurred (9) without a significant reduction in 
the frequency of Con A-responsive T cells. This would provide a natural mixture 
of transformed cells (candidate suppressor cells) and T cells (targets of suppres- 
sion).  Since the response of spleen cells from 4-day infected mice returned  to 
normal after the cells were washed (Fig. 1), the low Con A response of unwashed 
cells could be attributed  to extracellular  material.  However, this  experiment 
alone does not exclude a role for cell-mediated suppressive effects at later times 
when the frequency of leukemic cells is greater.  It was therefore necessary to 
test spleen cells from mice in later stages of leukemia, when the great majority 
of cells are known to have been transformed.  The fact that washed spleen cells 
even from 8-,  12-, and 21-day infected animals failed to suppress normal T-cell 
response to Con A excludes the possibility that suppression can be mediated by 
Friend erythroleukemic cells alone without the intervention of cell-free factors. 
Furthermore,  since thymus and lymph node,  unlike  spleen and bone marrow 
cell populations,  do not include erythropoietic progenitor cells (the target cells 
for  transformation)  it  follows that  FV  can  exert  biologic  effects directly  on 
immunocompetent  cells without  an  intervening  step of leukemic transforma- 
tion. 
From investigations of the effect of FV on B and T cells from several strains of 
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resistant to FV leukemogenesis in vivo (Fv-2 r~) were also relatively resistant to 
FV-induced suppression in vitro. Table III shows that the differences between 
susceptibility and resistance in vitro could not be related to the 11-2 genotype. 
The  data  is  consistent  with  the  possibility  that  Fv-2  controls  the  in  vitro 
resistance of lymphoid cells to FV.  However, since C58,  B10.D2, and B6 mice 
belong to the same ancestry group of mouse strains  (25),  genes other than Fv-2 
may control this property of lymphoid cells in vitro.  Further  genetic analysis 
using  (DBA  ×  B10.D2)F1 intercross  and backcross mice has indeed indicated 
that the Fv-2 gene does not control the resistance of mitogen-responsive lympho- 
cytes to FV. 
The most significant findings in the present set of experiments relate to the 
abrogation of in vitro genetic resistance of B6 T cells to FV by prior treatment of 
donor mice with s"Sr, which selectively abrogates their M-cell function without 
affecting any known T, B, or accessory cell function.  The lack of resistance in 
both 8~Sr-treated adult and untreated infant B6 mice suggests that the genetic 
resistance of spleen and thymus cells in vitro to FV depends upon functional M 
cells. Alternatively, 8ySr may have altered the sensitivity of mitogen-responsive 
lymphocytes to FV. This latter possibility has been tested and excluded in the 
accompanying paper (11). 
Treatment  of B6 mice with silica or MC  sarcomas suppressed marrow  allo- 
graft  rejection  but  did  not  weaken  their  genetic  resistance  to  FV-induced 
suppression  in  vitro  (Table  IV).  Such  B6  mice  also  remain  resistant  to  FV 
leukemia in vivo (unpublished observations). In this respect, the effect of 8sSr 
treatment is distinguishable from the effects of silica- and MC sarcomas.  Such 
data  suggest as one possibility that  resistance  to  FV is mediated by M  cells 
suppressible by s'~Sr and not by macrophages affected by silica. Alternatively, M 
cells may be a  subpopulation of macrophages and the differences between the 
effects  of sgSr  and  silica  may  be  quantitative  rather  than  qualitative,  s~Sr 
prevents  the  generation  of all  cells that  need to differentiate  in the  marrow 
while silica kills differentiated macrophages capable of phagocytosis. 
What is the possible relevance of these findings to Friend virus leukemogene- 
sis in vivo? Mice of strains highly susceptible to erythroleukemia induction by 
FV are severely immunosuppressed in vivo (26) and their lymphocytes respon- 
sive to mitogens are suppressed in vitro (Table III). B6 mice, which are highly 
resistant to erythroleukemia and are resistant to the immunosuppressive effects 
of FV in vivo (3), have lymphocytes which are not suppressed in vitro by FV to 
any  great  extent  (Table  III).  Furthermore,  treatment  of B6  mice  with  8sSr 
weakens the resistance of B6 mice to the malignant  erythropoietic and to the 
immunosuppressive effects of FV in vivo (4) and to the suppressive effect of FV 
in vitro  (Table IV).  These  correlations  suggest that  the  in vitro findings  are 
relevant to Friend disease. Since the Fv-2 gene does not control the property of 
resistance  of  mitogen-responsive  lymphocytes  to  FV  in  vitro, 2 it  would  be 
desirable to determine the resistance of Fv-2" mice congenic for this "resistance" 
gene of the B6 strain to FV leukemogenesis in vivo. We are breeding such mice 
at the present time. The data in Table III indicates that the gene(s) controlling 
this property of lymphocytes in vitro is not linked to the H-2  genetic region. 
Recovery  of mice  from  FV-induced  splenomegaly  appears  to  be  influenced VINAY  KUMAR  AND  MICHAEL  BENNETT  725 
favorably by functions of multiple genes of the C57BL/10 mice not linked to H-2 
(27). The gene(s) controlling resistance of lymphocytes to FV in vitro could be 
partly responsible for that  recovery. It appears  reasonable  to consider that  a 
gene protecting against the immunosuppressive effects of FV would also contrib- 
ute to recovery from its pathological effects. 
The mechanism by which M cells confer resistance to in vitro suppression of 
mitogenesis  by FV are not entirely clear.  In the following paper,  we present 
evidence to  indicate  that  M  cells  could act  by regulating  suppressor T  cells. 
These suppressor cells, upon activation  by FV infection in vitro, suppress the 
Con A-responsive T  cells which  are  not directly sensitive to FV.  In resistant 
mice, the function or numbers of suppressor T cells may be under the regulatory 
influence of M cells. 
Summary 
Friend leukemia virus suppresses the proliferative responses of normal thy- 
mus-dependent  (T)  and  bursa  equivalent-dependent  (B)  lymphocytes  from 
spleen,  thymus,  lymph node,  and bone marrow  to mitogens.  The suppressive 
effect of Friend  virus  complex  (FV)  requires  fully infectious  virions.  Friend 
erythroleukemic  cells,  washed to  remove extracellular  virus,  fail to suppress 
concanavalin A  (Con-A)-induced mitogenesis of normal spleen cells. This indi- 
cates that FV does not mediate  its immunosuppressive effect via transformed 
erythropoietic cells. 
The in vitro suppressive effect of FV on lymphocyte mitogenesis is under host 
genetic control.  Spleen,  bone marrow,  and thymus cells from strains  of mice 
susceptible to FV-induced leukemogenesis in vivo were quite susceptible to the 
suppressive effects of FV in vitro. On the other hand, similar cells from strains 
of mice such as C57BL/6 resistant to Friend erythroleukemia, were quite resist- 
ant to in vitro immunosuppression  by FV.  Mitogenesis of splenic T cells from 
resistant B6 mice, previously treated with s'Sr, became susceptible to suppres- 
sion by FV.  This indicated that  the in vitro resistance of lymphocytes to FV- 
induced suppression is not an intrinsic property of T  cells, but is controlled by 
marrow-dependent (M) cells which are selectively eliminated by treatment with 
s~Sr.  M-cell function does not develop in mice less than  3-wk old.  The Con A 
response of thymus cells from 2-wk-old B6 mice was susceptible to suppression 
by FV,  further  supporting  the concept that  M  cells may regulate  the genetic 
resistance to FV. 
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